MB Grožio terapijos studija Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 8,790 |
| - |
| 1,015 |
| 964 |
| - |
| 39.17 |
| 10.97 |
| 7,367 |
| 215 |
| 5,174 |
| 5,916 |
| 2023 |
|---|
| 9,223 |
| - |
| 525 |
| 499 |
| - |
| 42.20 |
| 5.41 |
| 7,756 |
| 88 |
| 1,547 |
| 6,784 |
| 2024 |
|---|
| 5,814 |
| - |
| -2,288 |
| -2,288 |
| - |
| 75.56 |
| -39.35 |
| 5,468 |
| 12 |
| 413 |
| 5,067 |
Register and
explore Okredo data| 2024 |
|---|
| 5,814 |
| - |
| -2,288 |
| -2,288 |
| - |
| 75.56 |
| -39.35 |
| 5,468 |
| 12 |
| 413 |
| 5,067 |
Register and
explore Okredo data2024
Turnover (€)
5,814 €
-37 % *
Sales per employee (€)
-Profit before tax (€)
-2,288 €-536 % *
Net Profit (€)
-2,288 €-559 % *
Profit per employee (€)
-Total profitability (%)
75.56 %
79.05 % *
Net profitability (%)
-39.35 %-827.36 % *
Equity (€)
5,468 €-30 % *
Amounts Payable And Liabilities (€)
12 €
-86 % *
Non-current Assets (€)
413 €-73 % *
CurrentAssets (€)
5,067 €-25 % *